e-learning
resources
Milan 2017
Sunday, 10.09.2017
Late-breaking findings in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Metabolomics in Exhaled Breath Condensate (EBC) of asthmatic patients. Does severity and methodology make the difference?
P. Ntontsi (Athens, Greece)
Source:
International Congress 2017 – Late-breaking findings in asthma and COPD
Session:
Late-breaking findings in asthma and COPD
Session type:
Thematic Poster
Number:
1352
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Ntontsi (Athens, Greece). Late Breaking Abstract - Metabolomics in Exhaled Breath Condensate (EBC) of asthmatic patients. Does severity and methodology make the difference?. 1352
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Measuring exhaled hydrogen sulphide (eH2S) levels in asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Exhaled breath temperature(EBT) in asthmatic patients: Influence of severity and underlying mechanisms
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Exhaled breath condensate pH in assessment of childhood asthma control
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Late Breaking Abstract - Effect of hydrogen therapy on the proteomic profile of exhaled breath condensate after recovery from COVID-19
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Exhaled breath condensate pH identifies children with preschool asthma
Source: Annual Congress 2013 –The best of paediatric asthma and allergy
Year: 2013
Exhaled nitric oxide in asthma: Relationship with breath gymnastic and FeNO levels
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
Exhaled breath condensate: metabolomics
Source: Eur Respir Monogr 2010; 49: 231-236
Year: 2010
Exhaled breath VOCs are associated with nocturnal wakening in asthmatic children
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Unbiased clustering of severe asthma patients based on exhaled breath profiles
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Exhaled particles from small airways in COPD patients – A pilot study
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Exhaled breath temperature in asthmatic and healthy children: A case-control study
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Influence of inflammatory phenotype in severe refractory asthma on metabolomic profile of oxidative stress in exhaled breath condensate (EBC)
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Exacerbations after stepping down medication in children with well-controlled asthma: predictive value of spirometry and nitrite/nitrate concentration and pH in exhaled breath condensate
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Determinants of variability in exhaled breath condensate (EBC) in children
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008
Exhaled NO and exhaled breath condensate pH in the assessment of asthma control: a real-life study
Source: Annual Congress 2009 - One size (does not) fit all: phenotyping and controlling asthma
Year: 2009
Oxidative stress in children with OSAS: 8-isoprostane values comparison in urine and exhaled breath condensate (EBC)
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015
Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept